ESSA Pharma Inc.·4

Dec 18, 9:57 PM ET

Parkinson David Ross 4

4 · ESSA Pharma Inc. · Filed Dec 18, 2023

Insider Transaction Report

Form 4
Period: 2023-12-14
Parkinson David Ross
DirectorPresident and CEO
Transactions
  • Purchase

    Common Shares

    2023-12-14$2.30/sh+9,223$21,21365,675 total
Footnotes (1)
  • [F1]The amount reflects the acquisition of shares pursuant to the ESSA Pharma Inc. Employee Stock Purchase Plan.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4